menu
    • menu

    Company profile for CANbridge Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CANbridge Pharmaceuticals Inc. is a China-focused biopharmaceutical company accelerating development and commercialization of specialty healthcare products for orphan diseases and targeted cancers, focusing on products that are unavailable or address medical needs that are underserved in the region. CANbridge has been recognized as a leader in orphan diseases in China. It has a global partnership with WuXi Biologics to deve...
    CANbridge Pharmaceuticals Inc. is a China-focused biopharmaceutical company accelerating development and commercialization of specialty healthcare products for orphan diseases and targeted cancers, focusing on products that are unavailable or address medical needs that are underserved in the region. CANbridge has been recognized as a leader in orphan diseases in China. It has a global partnership with WuXi Biologics to develop and commercialize proprietary therapeutics for the treatment of rare genetic diseases. In greater China, it has an exclusive licensing agreement to commercialize Hunterase®

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CANbridge PharmaceuticalsChina Flag
    Country
    Country
    China
    Address
    Address
    Suite 301,3F,Timeloit, No. 17 RongChuang Road, Chaoyang District, Beijing, Chi...
    Telephone
    Telephone
    010 84148018
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.canbridgepharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CANbridge Pharmaceuticals to Present Fabry Disease Gene Therapy Abstract
    CANbridge Pharmaceuticals to Present Fabry Disease Gene Therapy Abstract

    25 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/canbridge-pharmaceuticals-to-present-fabry-disease-gene-therapy-abstract-at-esgct-30th-annual-congress-301967247.html

    PR NEWSWIRE
    25 Oct 2023
    Share Share
    CANbridge Announces Enrollment Reached in Core Part of The CAN103 Phase 2 Trial
    CANbridge Announces Enrollment Reached in Core Part of The CAN103 Phase 2 Trial

    16 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/canbridge-announces-full-enrollment-reached-in-the-core-part-of-the-can103-phase-2-trial-for-gaucher-disease-in-china-301957062.html

    PR NEWSWIRE
    16 Oct 2023
    Share Share
    CANbridge Announces NDA Acceptance of CAN108 for Cholestatic Pruritus
    CANbridge Announces NDA Acceptance of CAN108 for Cholestatic Pruritus

    16 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/canbridge-announces-nda-acceptance-of-can108-livmarli-for-cholestatic-pruritus-in-progressive-familial-intrahepatic-cholestasis-pfic-by-chinas-national-medical-products-administration-301957678.html

    PR NEWSWIRE
    16 Oct 2023
    Share Share
    CANbridge Announces Marketing Approval of CAN108 (/LIVMARLI®) in Taiwan
    CANbridge Announces Marketing Approval of CAN108 (/LIVMARLI®) in Taiwan

    08 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/canbridge-announces-marketing-approval-of-can108-livmarli-in-taiwan-for-the-treatment-of-cholestatic-pruritus-in-patients-with-alagille-syndrome-algs-301950200.html

    PR NEWSWIRE
    08 Oct 2023
    Share Share
    CANbridge to Participate in Two Investor Conferences in September
    CANbridge to Participate in Two Investor Conferences in September

    06 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/canbridge-to-participate-in-two-investor-conferences-in-september-301918869.html

    PR NEWSWIRE
    06 Sep 2023
    Share Share
    CANbridge Announces Interim Financial Results and Corporate Updates
    CANbridge Announces Interim Financial Results and Corporate Updates

    31 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/canbridge-announces-interim-financial-results-and-corporate-updates-for-the-six-months-ended-june-30-2023-301914570.html

    PR NEWSWIRE
    31 Aug 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search